Structure analysis of the proteins associated with polyA repeat expansion disorders.

Poly alanine disorders protein structure tandem repeat disorders

Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 19 1 2021
medline: 14 7 2022
entrez: 18 1 2021
Statut: ppublish

Résumé

Repeat regions are low-complexity regions in the human genome that largely code for intrinsic disorder in proteins. Expansions outside the normal thresholds in repeat regions are likely to be pathogenic, leading to the so-called repeat expansion diseases. There have been numerous studies on the most common group of repeat expansion diseases, which are the polyglutamine (polyQ) repeat expansion diseases, but there has been much less work done on the second-largest group of expansion repeats disorders, which involves the expansion of polyalanine (polyA) repeat tracts. In this article, we present a comprehensive study of the structural changes predicted using I-TASSER when comparing the wild type and enlarged structures of all known polyA expansion disorders. The results show that there is a reduction in α helices, an increase in extended strands in parallel and/or anti-parallel β-sheet conformation, an increase in random coils/loops and irregular elements, and a large increase in solvent-accessible surface area. When compared to the findings in polyQ expansions disorders we see similar trends, suggesting that the polyQ and polyA repeat expansion causes similar effects on the respective proteins, which lead to higher misfolding and aggregation propensities.Communicated by Ramaswamy H. Sarma.

Identifiants

pubmed: 33459170
doi: 10.1080/07391102.2021.1871957
pmc: PMC8286276
mid: NIHMS1670936
doi:

Substances chimiques

Peptides 0
Proteins 0
polyalanine 25191-17-7

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5556-5565

Subventions

Organisme : NLM NIH HHS
ID : T15 LM007124
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001067
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States

Auteurs

Rolando Hernandez (R)

Department of Biomedical Informatics, The University of Utah, Salt Lake City, UT, USA.

Julio C Facelli (JC)

Department of Biomedical Informatics, The University of Utah, Salt Lake City, UT, USA.
Center for Clinical and Translational Science, The University of Utah, Salt Lake City, UT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH